Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Article 1Renewal of the approval of the active substance
In force · version of Mar 31, 2024
The approval of the active substance hydrolysed proteins, as specified in Annex I to this Regulation, is renewed, subject to the conditions laid down in that Annex.